Senti Biosciences Holdings (SNTI) Balance Sheet: Assets & Liabilities

Senti Biosciences Holdings (SNTI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Senti Biosciences Holdings reported total assets of $51.22M and total liabilities of $45.63M. Shareholders' equity was $5.59M, down 78.2% from $25.65M a year earlier. Total debt stood at $28.89M against $16.42M in cash and short-term investments, a net debt position of $12.47M. That puts debt-to-equity at 5.17, compared with 1.31 a year earlier.

Senti Biosciences Holdings Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Senti Biosciences Holdings, Inc. (SNTI) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	16.42	48.28	35.93	57.62	56.03	30.54	5.30
Short-Term Investments	0.00	0.34	0.04	40.94	1.16	0.00	12.53
Cash & Short-Term Investments	16.42	48.28	35.97	98.56	56.03	30.54	17.83
Accounts Receivable	0.32	0.16	0.11	0.63	0.48	0.32	0.08
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.26	0.58	17.57	3.39	0.28	0.86	0.85
Total Current Assets	23.27	58.96	71.20	102.58	60.19	31.71	18.76
Non-Current Assets
Property, Plant & Equipment (Net)	24.40	35.24	41.61	74.55	33.08	16.14	16.59
Long-Term Investments	3.53	0.00	1.82	3.37	3.26	0.00	0.00
Other Non-Current Assets	3.55	3.64	3.74	0.29	3.43	0.50	-16.59
Total Non-Current Assets	27.95	38.88	48.28	78.21	36.51	16.64	16.59
Total Assets	51.22	97.84	119.48	180.79	96.70	48.35	35.84
Current Liabilities
Accounts Payable	2.94	1.45	1.25	2.27	5.19	0.91	1.20
Short-Term Debt	5.33	4.75	4.13	1.99	1.74	1.52	0.00
Accrued Liabilities	2.92	3.41	5.93	10.87	2.67	2.00	-
Deferred Revenue	0.35	0.66	0.99	0.80	1.66	0.00	0.00
Other Current Liabilities	0.07	0.43	1.37	13.00	0.63	2.43	3.11
Total Current Liabilities	13.97	13.15	12.67	18.05	14.54	4.87	4.31
Non-Current Liabilities
Long-Term Debt	23.56	28.89	33.54	35.10	20.99	12.53	0.00
Other Non-Current Liabilities	0.15	0.15	6.36	0.37	0.80	89.66	0.00
Total Non-Current Liabilities	31.66	59.05	39.90	35.48	193.62	102.19	0.00
Total Liabilities	45.63	72.19	52.57	53.53	208.16	107.06	17.88
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-358.57	-297.13	-244.34	-173.29	-115.08	-59.76	-39.90
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	364.16	322.78	311.25	300.54	3.62	1.04	0.45
Shares Outstanding	30.88	4.83	4.57	4.41	4.37	-	-
Total Stockholders' Equity	5.59	25.65	66.91	127.26	-111.46	-58.71	17.97
Total Liabilities & Equity	51.22	97.84	119.48	180.79	96.70	48.35	35.84

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Senti Biosciences Holdings Balance Sheet

How much debt does Senti Biosciences Holdings have?

Senti Biosciences Holdings had total debt of $28.89M as of Dec 31, 2025, against $16.42M in cash and short-term investments. Its debt-to-equity ratio was 5.17. Total debt was $33.64M a year earlier.

What are Senti Biosciences Holdings's total assets?

Senti Biosciences Holdings reported total assets of $51.22M as of Dec 31, 2025, down 47.6% from $97.84M a year earlier. Total liabilities were $45.63M.

What is Senti Biosciences Holdings's shareholders' equity?

Senti Biosciences Holdings's shareholders' equity was $5.59M as of Dec 31, 2025, or about $0.18 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition